Former FDA commissioner says COVID-19 pandemic could be 'effectively' ended in 2021

In light of highly encouraging vaccine data from Pfizer and Moderna, former Food and Drug Administration Commissioner Scott Gottlieb predicts the COVID-19 pandemic can be "effectively" ended in 2021.
Gottlieb spoke with CNBC on Monday about Moderna's "great result" after the company said preliminary phase three data suggested its COVID-19 vaccine candidate is 94.5 percent effective. This announcement came a week after Pfizer said data suggested its own coronavirus vaccine candidate is more than 90 percent effective. If this data holds, Gottlieb told CNBC, "we may have two highly effective vaccines" against the coronavirus.
"Once we get these vaccines in sufficient quantities heading into 2021, the combination of the fact that a lot of the population will have already had COVID, combined with the fact that we'll be vaccinating the public with a highly effective vaccine, we could effectively end this pandemic in 2021 with our technology," Gottlieb said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Both vaccines still need to receive FDA approval. But if they do, Dr. Anthony Fauci, the nation's top infectious disease expert, has predicted the general public could potentially receive a COVID-19 vaccine by April 2021.
Gottlieb added on Twitter that "the acute phase of the U.S. pandemic will end in 2021." But for now, as COVID-19 cases continue to spike around the country, Gottlieb added that "we must work together to get through the next 3 months." Brendan Morrow
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Thrilling must-see operas for 2025
The Week Recommends From Carmen to Peter Grimes, these are the UK's top productions
By Irenie Forshaw, The Week UK Published
-
There is a 'third state' between life and death
Under the radar Cells can develop new abilities after their source organism dies
By Devika Rao, The Week US Published
-
Is it worth getting an interest-only mortgage?
The Explainer Your monthly payments may be cheaper but the full mortgage amount will need to be paid back eventually
By Marc Shoffman, The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published